Form 4: Bionano Genomics COO Mark Oldakowski Reports Routine Tax-Related Stock Withholding

Bionano Genomics' Chief Operating Officer, Mark Oldakowski, reported the withholding of 27 shares of common stock by the company to cover tax obligations related to a vested RSU award.

Summary

• The reporting person is Mark Oldakowski, Chief Operating Officer of Bionano Genomics, Inc. (BNGO).
• On June 3, 2025, 27 shares of Bionano Genomics common stock were disposed of by the reporting person.
• This disposition was a 'F' transaction code, indicating a withholding by the Issuer to satisfy tax obligations.
• The shares were withheld in connection with the vesting of a Restricted Stock Unit (RSU) award that was granted on June 3, 2024.
• The value of the shares at the time of withholding was $3.69 per share.
• Following this transaction, Mark Oldakowski beneficially owns 974 shares of Bionano Genomics common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to executive compensation and does not indicate a positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

This Form 4 filing is a report of a past transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing details a routine insider transaction related to executive compensation, specifically the tax withholding upon RSU vesting. It does not provide information relevant to broader industry trends or competitive dynamics within the genomics or biotechnology sector.

Stakeholder Impact

• The impact on shareholders is negligible, as the transaction represents a standard tax-related adjustment to an executive's compensation and does not reflect a discretionary sale or purchase of shares.

Key Dates

Keywords

Bionano Genomics, BNGO, Form 4, insider transaction, stock withholding, RSU, executive compensation, beneficial ownership